148 related articles for article (PubMed ID: 38592111)
41. The burden of anemia among Chinese HIV-infected patients following the initiation of antiretroviral therapy in the treat-all era: a nationwide cohort study.
Wei L; Zhao Y; Gan X; Zhao D; Wu Y; Dou Z; Ma Y
BMC Infect Dis; 2023 Oct; 23(1):704. PubMed ID: 37858044
[TBL] [Abstract][Full Text] [Related]
42. Comparative Safety and Changes in Immunologic and Virologic Parameters of Dolutegravir versus Efavirenz-Based Antiretroviral Therapies Among HIV Patients: A Retrospective Cohort Study.
Ayal MA; Berha AB
HIV AIDS (Auckl); 2023; 15():173-190. PubMed ID: 37139483
[TBL] [Abstract][Full Text] [Related]
43. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
[TBL] [Abstract][Full Text] [Related]
44. Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis.
Sunpath H; Edwin C; Chelin N; Nadesan S; Maharaj R; Moosa Y; Smeaton L; Court R; Knight S; Gwyther E; Murphy RA
Int J Tuberc Lung Dis; 2012 Jul; 16(7):917-23. PubMed ID: 22687498
[TBL] [Abstract][Full Text] [Related]
45. Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals.
Krishnan S; Schouten JT; Atkinson B; Brown T; Wohl D; McComsey GA; Glesby MJ; Shikuma C; Haubrich R; Tebas P; Campbell TB; Jacobson DL
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):381-9. PubMed ID: 22828718
[TBL] [Abstract][Full Text] [Related]
46. Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia.
Damtie D; Yismaw G; Woldeyohannes D; Anagaw B
BMC Res Notes; 2013 Dec; 6():534. PubMed ID: 24330921
[TBL] [Abstract][Full Text] [Related]
47. Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy.
Suwanpimolkul G; Gatechompol S; Kawkitinarong K; Ueaphongsukkit T; Sophonphan J; Siriyakorn N; Jirajariyavej S; Khusuwan S; Panarat P; Wannalerdsakun S; Saetiew N; Chayangsu S; Wiwatrojanagul S; Noopetch P; Danpornprasert P; Mekviwattanawong S; Fujitnirun C; Lertpiriyasuwat C; Han WM; Kerr SJ; Ruxrungtham K; Avihingsanon A;
J Int AIDS Soc; 2022 Apr; 25(4):e25900. PubMed ID: 35384317
[TBL] [Abstract][Full Text] [Related]
48. Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study.
Dembelu M; Kote M; Gilano G; Mohammed T
PLoS One; 2021; 16(12):e0261454. PubMed ID: 34972122
[TBL] [Abstract][Full Text] [Related]
49. Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study.
Mega TA; Usamo FB; Negera GZ
BMC Pediatr; 2020 Mar; 20(1):99. PubMed ID: 32126978
[TBL] [Abstract][Full Text] [Related]
50. Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa.
Leroi C; Balestre E; Messou E; Minga A; Sawadogo A; Drabo J; Maiga M; Zannou M; Seydi M; Dabis F; Jaquet A;
PLoS One; 2017; 12(1):e0170753. PubMed ID: 28122041
[TBL] [Abstract][Full Text] [Related]
51. Incidence of hypertension among persons living with HIV in China: a multicenter cohort study.
Fan H; Guo F; Hsieh E; Chen WT; Lv W; Han Y; Xie J; Li Y; Song X; Li T
BMC Public Health; 2020 Jun; 20(1):834. PubMed ID: 32487185
[TBL] [Abstract][Full Text] [Related]
52. Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART.
Nuwagaba-Biribonwoha H; Kiragga AN; Yiannoutsos CT; Musick BS; Wools-Kaloustian KK; Ayaya S; Wolf H; Lugina E; Ssali J; Abrams EJ; Elul B;
J Int AIDS Soc; 2018 Sep; 21(9):e25178. PubMed ID: 30225908
[TBL] [Abstract][Full Text] [Related]
53. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
Pathmanathan I; Dokubo EK; Shiraishi RW; Agolory SG; Auld AF; Onotu D; Odafe S; Dalhatu I; Abiri O; Debem HC; Bashorun A; Ellerbrock T
PLoS One; 2017; 12(3):e0173309. PubMed ID: 28282390
[TBL] [Abstract][Full Text] [Related]
54. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
55. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.
Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M
BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289
[TBL] [Abstract][Full Text] [Related]
56. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
Haddow LJ; Moosa MY; Mosam A; Moodley P; Parboosing R; Easterbrook PJ
PLoS One; 2012; 7(11):e40623. PubMed ID: 23152745
[TBL] [Abstract][Full Text] [Related]
57. Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study.
Wondifraw EB; Tefera BD; Zeleke M; Nebyu S; Tilahun L; W/Selassie M; Tefera Z
Ann Med Surg (Lond); 2022 Dec; 84():104910. PubMed ID: 36536709
[TBL] [Abstract][Full Text] [Related]
58. A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, China.
Zhong M; Li M; Qi M; Su Y; Yu N; Lv R; Ye Z; Zhang X; Xu X; Cheng C; Chen C; Wei H
Front Immunol; 2022; 13():1033098. PubMed ID: 36700216
[TBL] [Abstract][Full Text] [Related]
59. Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi.
van Lettow M; Åkesson A; Martiniuk AL; Ramsay A; Chan AK; Anderson ST; Harries AD; Corbett E; Heyderman RS; Zachariah R; Bedell RA
PLoS One; 2012; 7(11):e48856. PubMed ID: 23185278
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of Opportunistic Infections and Associated Factors in HIV-Infected Men Who Have Sex With Men on Antiretroviral Therapy in Bach Mai Hospital, Hanoi, Vietnam: A Case-Control Study.
Dang LVP; Nguyen QH; Ishizaki A; Larsson M; Vu NTP; Do Duy C; Olson L; Dinh TT
Am J Mens Health; 2020; 14(3):1557988320926743. PubMed ID: 32552402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
